OZAWADE Trademark

Trademark Overview

On Friday, March 19, 2021, a trademark application was filed for OZAWADE with the United States Patent and Trademark Office. The USPTO has given the OZAWADE trademark a serial number of 79312736. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by BIOPROJET EUROPE LIMITED. The OZAWADE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for treating respiratory diseases
ozawade

General Information

Serial Number79312736
Word MarkOZAWADE
Filing DateFriday, March 19, 2021
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6749352
Registration DateTuesday, June 7, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 1, 2022

Trademark Statements

Goods and ServicesPharmaceutical products for treating respiratory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOPROJET EUROPE LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIE
Party NameBIOPROJET EUROPE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIE
Party NameBIOPROJET EUROPE LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIE

Trademark Events

Event DateEvent Description
Sunday, October 24, 2021ASSIGNED TO EXAMINER
Thursday, June 10, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 15, 2021APPLICATION FILING RECEIPT MAILED
Saturday, October 30, 2021NON-FINAL ACTION WRITTEN
Friday, December 3, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, October 31, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 3, 2021REFUSAL PROCESSED BY MPU
Sunday, December 26, 2021REFUSAL PROCESSED BY IB
Monday, December 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 30, 2021ASSIGNED TO LIE
Wednesday, December 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 12, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 12, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, January 30, 2022NOTIFICATION PROCESSED BY IB
Tuesday, February 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 30, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 7, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, August 30, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, October 10, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, September 20, 2022FINAL DISPOSITION PROCESSED
Tuesday, September 20, 2022FINAL DISPOSITION NOTICE SENT TO IB

Related Keywords

ozawade diseases respiratory treating products pharmaceutical